Bio-Synthesis specialises in custom peptide synthesis from small to large scale and can help design the optimal peptides for your research needs at the most competitive price and the highest quality
The DNA Synthesis division of Bio-Synthesis has a new custom service: Mini Gene Synthesis.
With the capability to synthesise 100-200 bases long oligonucleotides, BSI can put small genes together.
A small gene can be defined as one that encodes for 30-60 residues in length.
The ability to chemically synthesise proves very useful to biomedical researchers studying control of gene expression.
A mini gene can code for a peptide that can be an antagonist to a regulatory protein.
BSI can deliver mini genes in about 5-7 days.
Bio-Synthesis, headquartered in Dallas, Texas is a biomedical manufacturer of custom peptide synthesis, polyclonal antibodies, bioconjugates, DNA oligomer, HLA/DNA typing, organic synthesis and a diverse number of bimolecular products for the biomedical/life science community worldwide.
It was the first commercial company providing DNA and peptides in 1984 and has assisted biomedical researchers (and published articles) in the design of complex bimolecular, of >600,000 peptides used in a variety of fields including but not limited to cancer, apoptosis, signal transduction, cell cycle regulation, genomic sequencing, microarrays, epitope mapping, and HLA typing.
It has capabilities to synthesise over 500 peptides simultaneously with over 22 years of experienced manufacturing.
